BAKU, Azerbaijan, Jan. 18
By Elnur Baghishov – Trend:
About $210 million has been saved since the beginning of current Iranian year (March 20, 2020) with the domestic production of biotechnology products in Iran, Trend reports citing official website of Vice-Presidency for Science and Technology.
This was reflected in the report of the Committee on Biotechnology Development of the Vice President of Science and Technology of Iran.
According to the report, in this regard, 90 types of biotechnology products were produced in Iran, and as a result, these funds were returned to the Iranian treasury.
“$116 million was saved by producing raw materials for 75 types of medicines, $60 million - by producing 5 types of human vaccines, and $24 million - by producing 3 types of medical equipment, the report said.
According to the report, the Committee for the Development of Biotechnology in Iran continues to work for development of domestic production.